161 related articles for article (PubMed ID: 31690262)
21. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
23. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
[TBL] [Abstract][Full Text] [Related]
24. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
Wang Z; Yang L; Xia Y; Guo C; Kong L
Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
[TBL] [Abstract][Full Text] [Related]
25. Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model.
Grilli A; Sciandra M; Terracciano M; Picci P; Scotlandi K
BMC Med Genomics; 2015 Jun; 8():34. PubMed ID: 26123714
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional Pt(iv) complexes containing a glutathione S-transferase inhibitor lead to enhancing anticancer activity and preventing metastasis of osteosarcoma cells.
Chen H; Chen F; Wang X; Gou S
Metallomics; 2019 Feb; 11(2):317-326. PubMed ID: 30560252
[TBL] [Abstract][Full Text] [Related]
27. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
29. Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2.
Shang D; Wu J; Guo L; Xu Y; Liu L; Lu J
Int J Oncol; 2017 May; 50(5):1848-1856. PubMed ID: 28393220
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
[TBL] [Abstract][Full Text] [Related]
32. The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
Mukherjee S; Dash S; Lohitesh K; Chowdhury R
PLoS One; 2017; 12(6):e0179203. PubMed ID: 28598976
[TBL] [Abstract][Full Text] [Related]
33. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
Ansell A; Jerhammar F; Ceder R; Grafström R; Grénman R; Roberg K
Oral Oncol; 2009 Oct; 45(10):866-71. PubMed ID: 19442568
[TBL] [Abstract][Full Text] [Related]
35. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.
Kun-Peng Z; Xiao-Long M; Chun-Lin Z
Int J Biol Sci; 2018; 14(3):321-330. PubMed ID: 29559849
[TBL] [Abstract][Full Text] [Related]
36. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
37. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
Ong PS; Chan SY; Ho PC
Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
[TBL] [Abstract][Full Text] [Related]
38. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
[TBL] [Abstract][Full Text] [Related]
39. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
[TBL] [Abstract][Full Text] [Related]
40. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
